医学
脊髓损伤
物理疗法
干预(咨询)
压力伤
截瘫
康复
物理医学与康复
脊髓
护理部
精神科
作者
Mike Carlson,Cheryl Vigen,Salah Rubayi,Erna Imperatore Blanche,Jeanine Blanchard,Michal Atkins,Barbara M. Bates‐Jensen,Susan L. Garber,Elizabeth A. Pyatak,Jesús Díaz,Lucía I. Floríndez,Joel W. Hay,Trudy Mallinson,Jennifer B. Unger,Stanley P. Azen,Michael D. Scott,Alison M. Cogan,Florence Clark
标识
DOI:10.1080/10790268.2017.1313931
摘要
CONTEXT/OBJECTIVE: Medically serious pressure injuries (MSPrIs), a common complication of spinal cord injury (SCI), have devastating consequences on health and well-being and are extremely expensive to treat. We aimed to test the efficacy of a lifestyle-based intervention designed to reduce incidence of MSPrIs in adults with SCI. DESIGN: A randomized controlled trial (RCT), and a separate study wing involving a nonrandomized standard care control group. SETTING: Rancho Los Amigos National Rehabilitation Center, a large facility serving ethnically diverse, low income residents of Los Angeles County. PARTICIPANTS: Adults with SCI, with history of one or more MSPrIs over the past 5 years: N=166 for RCT component, N=66 in nonrandomized control group. INTERVENTIONS: The Pressure Ulcer Prevention Program, a 12-month lifestyle-based treatment administered by healthcare professionals, largely via in-home visits and phone contacts. OUTCOME MEASURES: Blinded assessments of annualized MSPrI incidence rates at 12 and 24 months, based on: skin checks, quarterly phone interviews with participants, and review of medical charts and billing records. Secondary outcomes included number of surgeries and various quality-of-life measures. RESULTS: Annualized MSPrI rates did not differ significantly between study groups. At 12 months, rates were .56 for intervention recipients, .48 for randomized controls, and .65 for nonrandomized controls. At follow-up, rates were .44 and .39 respectively for randomized intervention and control participants. CONCLUSIONS: Evidence for intervention efficacy was inconclusive. The intractable nature of MSPrI threat in high-risk SCI populations, and lack of statistical power, may have contributed to this inability to detect an effect. TRIAL REGISTRATION: ClinicalTrials.gov NCT01999816.
科研通智能强力驱动
Strongly Powered by AbleSci AI